methylmalonic acidemia with homocystinuria, type cblJ

disease
On this page

Also known as cblJ defectscobalamin J defectcombined defect in adenosylcobalamin and methylcobalamin synthesis, type cblJMAHCJmethylmalonic acidemia with homocystinuria type cblJmethylmalonic aciduria and homocystinuria, cblJ typemethylmalonic aciduria with homocystinuria, type cblJ

Summary

methylmalonic acidemia with homocystinuria, type cblJ (MONDO:0013925) is a disease caused by ABCD4 (GenCC Strong), with 1 cohort gene.

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Causal gene: ABCD4 (GenCC Strong)
  • Cohort genes: 1
  • ClinVar variants: 363

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families2WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Identifiers

Disease identifiers

FieldValue
Canonical namemethylmalonic acidemia with homocystinuria, type cblJ
Mondo IDMONDO:0013925
OMIM614857
Orphanet369955
UMLSC3553915
MedGen766829
GARD0012621
Is cancer (heuristic)no

Also known as: cblJ defects · cobalamin J defect · combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblJ · MAHCJ · methylmalonic acidemia with homocystinuria type cblJ · methylmalonic aciduria and homocystinuria, cblJ type · methylmalonic aciduria with homocystinuria, type cblJ

Data availability: 363 ClinVar variants · 5 GenCC gene-disease records · 6 cell lines.

Disease family

Classification path: human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseaseinborn errors of metabolism › inborn disorder of amino acid and other organic acid metabolism › inborn disorder of amino acid metabolisminborn organic aciduriamethylmalonic acidemiamethylmalonic aciduria and homocystinuriamethylmalonic acidemia with homocystinuria, type cblJ

Related subtypes (5): methylmalonic aciduria and homocystinuria type cblF, methylmalonic aciduria and homocystinuria type cblC, methylmalonic aciduria and homocystinuria type cblD, methylmalonic acidemia with homocystinuria, type cblX, methylmalonic aciduria and homocystinuria, cb1L type

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

363 retrieved; paginated sample, class counts are floors:

164 likely benign, 114 uncertain significance, 24 benign, 18 pathogenic, 18 likely pathogenic, 13 conflicting classifications of pathogenicity, 9 benign/likely benign, 3 pathogenic/likely pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
1069117NM_005050.4(ABCD4):c.1294del (p.Arg432fs)ABCD4Pathogeniccriteria provided, single submitter
1335925NM_005050.4(ABCD4):c.1125del (p.Trp377fs)ABCD4Pathogeniccriteria provided, multiple submitters, no conflicts
1343599NM_005050.4(ABCD4):c.423C>G (p.Asn141Lys)ABCD4Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
1453520NC_000014.8:g.(?74766231)(74769615_?)delABCD4Pathogeniccriteria provided, single submitter
1941455NM_005050.4(ABCD4):c.1213_1214dup (p.Asp406fs)ABCD4Pathogeniccriteria provided, single submitter
2141575NM_005050.4(ABCD4):c.373del (p.Arg125fs)ABCD4Pathogeniccriteria provided, single submitter
2728334NM_005050.4(ABCD4):c.1606C>T (p.Arg536Ter)ABCD4Pathogeniccriteria provided, single submitter
2752020NM_005050.4(ABCD4):c.1158dup (p.Phe387fs)ABCD4Pathogeniccriteria provided, single submitter
2784087NM_005050.4(ABCD4):c.7dup (p.Val3fs)ABCD4Pathogeniccriteria provided, single submitter
280107NM_005050.4(ABCD4):c.542+1G>TABCD4Pathogeniccriteria provided, multiple submitters, no conflicts
2843505NM_005050.4(ABCD4):c.1438G>T (p.Glu480Ter)ABCD4Pathogeniccriteria provided, single submitter
3013548NM_005050.4(ABCD4):c.454C>T (p.Arg152Ter)ABCD4Pathogeniccriteria provided, single submitter
3576745NM_005050.4(ABCD4):c.528C>A (p.Tyr176Ter)ABCD4Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
3721580NM_005050.4(ABCD4):c.442C>T (p.Gln148Ter)ABCD4Pathogeniccriteria provided, single submitter
37320NM_005050.4(ABCD4):c.1746_1747insCT (p.Glu583fs)ABCD4Pathogenicno assertion criteria provided
37322NM_005050.4(ABCD4):c.1456G>T (p.Gly486Cys)ABCD4Pathogenicno assertion criteria provided
4705101NM_005050.4(ABCD4):c.1346del (p.Thr449fs)ABCD4Pathogeniccriteria provided, single submitter
4733104NM_005050.4(ABCD4):c.131del (p.Leu44fs)ABCD4Pathogeniccriteria provided, single submitter
4744293NM_005050.4(ABCD4):c.1246_1247del (p.Ser416fs)ABCD4Pathogeniccriteria provided, multiple submitters, no conflicts
4767717NM_005050.4(ABCD4):c.643del (p.Gln215fs)ABCD4Pathogeniccriteria provided, single submitter
583152NM_005050.4(ABCD4):c.1588C>T (p.Gln530Ter)ABCD4Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
1698540NM_005050.4(ABCD4):c.1295G>A (p.Arg432Gln)ABCD4Likely pathogeniccriteria provided, multiple submitters, no conflicts
2664286NM_005050.4(ABCD4):c.301del (p.Gln101fs)ABCD4Likely pathogeniccriteria provided, single submitter
2720728NM_005050.4(ABCD4):c.1457-1G>CABCD4Likely pathogeniccriteria provided, single submitter
3576735NM_005050.4(ABCD4):c.1343_1349delinsCCCATGGG (p.Leu448fs)ABCD4Likely pathogeniccriteria provided, single submitter
3576737NM_005050.4(ABCD4):c.1237G>T (p.Glu413Ter)ABCD4Likely pathogeniccriteria provided, single submitter
3576738NM_005050.4(ABCD4):c.1118+1G>TABCD4Likely pathogeniccriteria provided, single submitter
3576739NM_005050.4(ABCD4):c.936+1G>AABCD4Likely pathogeniccriteria provided, single submitter
3576740NM_005050.4(ABCD4):c.767dup (p.Leu257fs)ABCD4Likely pathogeniccriteria provided, single submitter
3576741NM_005050.4(ABCD4):c.708del (p.Ala237fs)ABCD4Likely pathogeniccriteria provided, multiple submitters, no conflicts

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 5 · Orphanet: 1 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
ABCD4StrongAutosomal recessivemethylmalonic acidemia with homocystinuria, type cblJ5

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
ABCD4Orphanet:369955Methylmalonic acidemia with homocystinuria, type cblJ

Cohort genes → proteins

1 cohort genes, 1 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence1

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
ABCD4HGNC:68ENSG00000119688O14678Lysosomal cobalamin transporter ABCD4gencc,clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
ABCD4Lysosomal cobalamin transporter ABCD4Lysosomal membrane protein that transports cobalamin (Vitamin B12) from the lysosomal lumen to the cytosol in an ATP-dependent manner.

Protein-family classification

Druggable: 1 · Difficult: 0 · Unknown: 0 · Druggable fraction: 1.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Transporter177.8×0.013

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
ABCD4Transporteryes7.6.2.8ABC_transporter-like_ATP-bd, AAA+_ATPase, ABC1_TM_dom

Expression context

Cohort genes with no expression data: 0.

1 cohort gene are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)1
unknown0

Top tissues across cohort

TissueCohort genes
right hemisphere of cerebellum1
right ovary1
right uterine tube1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
ABCD4259ubiquitousmarkerright uterine tube, right hemisphere of cerebellum, right ovary

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
ABCD41,327

Structural data

PDB: 1 · AlphaFold-only: 0 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
ABCD4O146781

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 13. Enrichment computed across 1 evidence-associated genes (1 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Defective ABCD4 causes MAHCJ15710.0×0.002ABCD4
Transport of RCbl within the body11427.5×0.004ABCD4
Uptake of dietary cobalamins into enterocytes11142.0×0.004ABCD4
Defects in cobalamin (B12) metabolism1815.7×0.004ABCD4
Cobalamin (Cbl, vitamin B12) transport and metabolism1634.4×0.004ABCD4
Defects in vitamin and cofactor metabolism1601.0×0.004ABCD4
ABC transporter disorders1439.2×0.004ABCD4
Metabolism of water-soluble vitamins and cofactors1181.3×0.009ABCD4
Disorders of transmembrane transporters1139.3×0.010ABCD4
Metabolism of vitamins and cofactors1116.5×0.011ABCD4
Diseases of metabolism180.4×0.015ABCD4
Disease113.1×0.083ABCD4
Metabolism111.6×0.086ABCD4

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
long-chain fatty acid import into peroxisome13370.4×0.001ABCD4
very long-chain fatty acid catabolic process12407.4×0.001ABCD4
cobalamin transport11872.4×0.001ABCD4
cobalamin metabolic process11532.0×0.001ABCD4
peroxisome organization1802.5×0.002ABCD4
fatty acid beta-oxidation1374.5×0.004ABCD4
transmembrane transport1168.5×0.006ABCD4
cellular response to leukemia inhibitory factor1159.0×0.006ABCD4

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1

Druggability breadth: 0 of 1 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
ABCD400

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 1.

Cohort enzymes (BRENDA EC)

SymbolEC numbersNames
ABCD47.6.2.8ABC-type vitamin B12 transporter

Pharmacogenomics

Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug1ABCD4
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug0

Undrugged target profiles

1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
ABCD40

Clinical trials & evidence

Clinical trials

Clinical trials: 0.